We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 424

Tech interests praise USPTO director nomination
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

According to a news source, technology industry interests have lauded President Barack Obama's (D) choice for U.S. Patent and Trademark Office


News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • October 30 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry titled "Circumstances that Constitute Delaying, Denying, Limiting


WSJ points to America Invents Act Scrivener’s error on post-grant review procedure
  • Shook Hardy & Bacon LLP
  • USA
  • October 31 2013

While some business interests are apparently willing to use the new post-grant review procedures before the U.S. Patent and Trademark Office (USPTO


Commenters weigh-in on USPTO’s “true owner” disclosure proposal
  • Shook Hardy & Bacon LLP
  • USA
  • February 8 2013

Among those commenting on a U.S. Patent and Trademark Office (USPTO) proposal to collect and disseminate information about the real-party-in-interest


News bytes - 24 January 2013
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2013

The U.S. Patent and Trademark Office (USPTO) publishes its final rule setting or adjusting patent fees under the Leahy-Smith America Invents Act


Considering end-user interests in patent-law reforms
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

Seton Hall University School of Law Professor Gaia Bernstein analyzes the rising role of end users in the patent-litigation landscape and argues that


Drug patent-protection incentives needed?
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2014

Noting that several members of Congress recently demanded that a pharmaceutical company justify the high cost of its hepatitis C drug, the


New infringement lawsuit filed to protect BRCA1 and BRCA2 patents
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

Myriad Genetics has brought a new infringement lawsuit against a company offering a next-generation sequencing test that analyzes the BRCA1 and BRCA2


News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

The U.S. Patent and Trademark Office (USPTO) requests nominations for open three-year positions on the Patent Public Advisory Committee and Trademark


USPTO proposes changes to patent term adjustment
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

In response to the Federal Circuit Court of Appeals ruling in Novartis AG v. Lee, summarized in Issue 71 of this Bulletin, the U.S. Patent and